Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q4 2025

Type / Class
Equity / Class A Common Stock, $0.001 par value per share
Symbol
CTNM on Nasdaq
Shares outstanding
30,273,764
Price per share
$14.88
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
29,575,131
Total reported value
$337,955,086
% of total 13F portfolios
0%
Share change
+12,033,429
Value change
+$137,435,356
Number of holders
79
Price from insider filings
$14.88
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 7.9% $27,991,830 2,448,979 JANUS HENDERSON GROUP PLC 31 Dec 2025
BALYASNY ASSET MANAGEMENT L.P. 7.6% $26,435,304 2,312,800 Balyasny Asset Management L.P. 31 Dec 2025
RA CAPITAL MANAGEMENT, L.P. 7.2% -27% $24,914,097 +$659,637 2,179,711 +2.7% RA Capital Management, L.P. 31 Dec 2025
FRANKLIN RESOURCES INC 6.2% -19% $21,479,661 +$2,558,072 1,879,367 +14% Franklin Resources, Inc. 31 Dec 2025
SECTORAL ASSET MANAGEMENT INC 5% $4,297,553 950,786 Jerome G. Pfund 31 Dec 2024
PERCEPTIVE ADVISORS LLC 3.2% -54% $2,776,959 -$2,944,799 699,486 -51% Perceptive Advisors LLC 30 Jun 2025

As of 31 Dec 2025, 79 institutional investors reported holding 29,575,131 shares of Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM). This represents 98% of the company’s total 30,273,764 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) together control 88% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SUVRETTA CAPITAL MANAGEMENT, LLC 9.4% 2,841,334 +65% 0.81% $32,476,448
JANUS HENDERSON GROUP PLC 8.1% 2,448,979 0.01% $27,906,116
RA CAPITAL MANAGEMENT, L.P. 7.2% 2,179,711 +2.7% 0.26% $24,914,097
JOHNSON & JOHNSON 6.5% 1,979,173 0% 4.1% $22,621,947
FRANKLIN RESOURCES INC 6.2% 1,879,367 +14% 0.01% $21,481,165
Balyasny Asset Management L.P. 6.1% 1,842,800 +94% 0.04% $21,063,204
PERCEPTIVE ADVISORS LLC 4.8% 1,464,592 +105% 0.31% $16,740,287
BAKER BROS. ADVISORS LP 4.7% 1,420,838 +1729% 0.1% $16,240,178
VANGUARD GROUP INC 4.2% 1,270,858 +32% 0% $14,525,907
MILLENNIUM MANAGEMENT LLC 2.7% 830,687 +29% 0.01% $9,494,752
Commodore Capital LP 2.7% 816,326 0.62% $9,330,606
FMR LLC 2.7% 814,871 0% 0% $9,313,976
SECTORAL ASSET MANAGEMENT INC 2.6% 800,787 0% 7.3% $9,152,995
GREAT POINT PARTNERS LLC 2.6% 800,000 3% $9,144,000
Point72 Asset Management, L.P. 2.5% 759,227 +107% 0.01% $8,677,965
HHLR ADVISORS, LTD. 2.2% 669,337 0% 0.25% $7,650,522
RED TREE MANAGEMENT, LLC 2.1% 638,158 0% 6.7% $7,294,146
Versant Venture Management, LLC 1.8% 542,628 0% 4.1% $6,202,238
BlackRock, Inc. 1.8% 536,155 +66% 0% $6,128,253
Boxer Capital Management, LLC 1.6% 494,000 1.2% $5,646,420
Longaeva Partners L.P. 1.6% 470,000 0.64% $5,372,100
SILVERARC CAPITAL MANAGEMENT, LLC 1% 307,540 +85% 0.51% $3,515,182
Ikarian Capital, LLC 0.93% 282,874 0.42% $3,233,250
ADAR1 Capital Management, LLC 0.92% 278,961 +258% 0.24% $3,188,524
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.88% 265,761 +30% 0% $3,037,648

Institutional Holders of Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 29,575,131 $337,955,086 +$137,435,356 $11.43 79
2025 Q3 17,478,081 $205,365,503 +$48,626,432 $11.75 61
2025 Q2 13,856,430 $55,287,652 -$6,405,461 $3.97 68
2025 Q1 15,121,377 $105,552,026 -$10,223,173 $6.98 62
2024 Q4 15,761,089 $230,901,673 +$20,179,605 $14.65 60
2024 Q3 13,713,806 $258,404,333 +$11,041,962 $19.14 52
2024 Q2 13,016,510 $229,220,181 +$229,145,565 $17.61 49